These tablets are available in strengths of 25 mg, 50 mg, 100 mg, and 200 mg, and they are intended to serve as a generic version of Toprol-XL® Tablets by Sequel Therapeutics, LLC. The manufacturing ...

Global pharma major Lupin Limited (Lupin) on Wednesday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application ...

August 11, 2006 — The US Food and Drug Administration (FDA) has approved first-time generic formulations of an estradiol transdermal system for the treatment of menopausal symptoms and hypoestrogenism ...

The FDA has announced a nationwide recall of over 13,000 bottles of Dr. Reddy’s Laboratories‘ Metoprolol Succinate Extended-Release Tablets, the generic version of AstraZeneca’s Toprol XL. The recall ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

New Delhi: Granules India Limited announced Tuesday that its Metoprolol Succinate Extended-Release Tablets have received US Food & Drug Administration (US FDA) approval for an abbreviated new drug ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

According to the notification issued on August 18, 1306 samples were tested and 1252 samples were declared as "of Standard Quality." Global pharma major Lupin Limited on Wednesday announced that it ...

The U.S. Food and Drug Administration (U.S. FDA) has approved Granules India’s abbreviated new drug application for hypertension drug Metoprolol Succinate Extended-Release Tablets USP, 25 mg, 50 mg, ...

The largest clinical trial ever in chronic heart failure (HF) and the first head-to-head comparison of the effects of 2 beta-blockers on major outcomes has been reported by the investigators to show ...